Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abbott Laboratories

Abbott Laboratories (ABT) Stock Overview

Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.

ABT●NYSE
HealthcareMedical - Devices
$116.64
$2.50(2.19%)
U.S. Market opens in 63h 26m

Abbott Laboratories (ABT)

Meyka AI Score

Z

Key Financials

Market Cap201.8B
P/E Ratio37.47
EPS (TTM)$5.21
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$111.21
3 Months$82.72
1 Year Target$121.78

ABT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Abbott Laboratories (NYSE: ABT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Abbott Laboratories's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABT on the NYSE shows an RSI of 77.98, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $121.78 for the NYSE listing.

Key metrics behind Abbott Laboratories's NYSE-traded stock include a P/E ratio of 37.47 and a market capitalization of 201.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABT on the NYSE.

Price Performance (NYSE: ABT)

1-Day Change
2.18%
5-Day Change
4.61%
1-Month Change
17.02%
3-Month Change
32.88%
6-Month Change
3.94%
Year-to-Date (YTD) Change
-6.91%
1-Year Change
-11.64%
3-Year Change
12.28%
5-Year Change
-7.32%
All-Time (Max) Change
70735.10%

Contact Information

https://www.abbott.com
224 667 6100
100 Abbott Park Road, Abbott Park, IL, 60064-6400

Company Facts

1,150,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions